ACADIA Pharmaceuticals Inc (ACAD)
Debt-to-equity ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 732,793 | 431,755 | 400,413 | 540,894 | 627,009 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $732,793K
= 0.00
The debt-to-equity ratio for ACADIA Pharmaceuticals Inc over the years 2020 to 2024 consistently stands at 0.00. This indicates that the company has been entirely funded by equity during these periods and has not taken on any debt to finance its operations or growth. A debt-to-equity ratio of 0.00 indicates a conservative financial structure where the company is not relying on debt to finance its activities. This can be interpreted positively as it signifies a lower financial risk for the company, as it does not have debt obligations that need to be repaid. However, it is also worth noting that a very low debt-to-equity ratio may potentially suggest underutilization of debt for potential growth opportunities or tax advantages that debt financing can offer.
Peer comparison
Dec 31, 2024